Literature DB >> 20177854

[Inhalation injury--epidemiology, diagnosis and therapy].

Ulrich Thaler1, Paul Kraincuk, Lars-Peter Kamolz, Manfred Frey, Philipp G H Metnitz.   

Abstract

OBJECTIVE: Inhalation injury is a vitally threatening medical syndrome, which might appear in patients with or without burn injuries. Thus, knowledge about development, diagnosis and treatment of inhalation injury should be available for each physician working in an intensive care unit.
METHODS: This review starts with the causal and formal pathogenesis of inhalation injuries. Furthermore, diagnosis and treatment in the critical care setting are presented, followed by the discussion of possible complications. Specific intoxications such as carbon monoxide are due to their importance separately discussed.
CONCLUSIONS: Inhalation injury present with an attributable excess mortality and thus worsen the prognosis of burned patients. New insights into the pathogenesis of inhalation injury, however, have led to improved therapeutic possibilities with improved outcome. Necessary prerequisites are a timely diagnosis and restrictive volume management, especially in patients with extensive burns. Prospective studies are needed to be able to answer the many emerging questions.

Entities:  

Mesh:

Year:  2010        PMID: 20177854     DOI: 10.1007/s00508-010-1303-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  78 in total

1.  Assessment of severity of ovine smoke inhalation injury by analysis of computed tomographic scans.

Authors:  Myung S Park; Leopoldo C Cancio; Andriy I Batchinsky; Michael J McCarthy; Bryan S Jordan; William W Brinkley; Michael A Dubick; Cleon W Goodwin
Journal:  J Trauma       Date:  2003-09

2.  Antithrombin deficiency and its relationship to severe burns.

Authors:  M Niedermayr; W Schramm; L Kamolz; D Andel; W Römer; K Hoerauf; M Zimpfer; H Andel
Journal:  Burns       Date:  2006-11-22       Impact factor: 2.744

Review 3.  Diagnosis and treatment of cyanide toxicity.

Authors:  David J Barillo
Journal:  J Burn Care Res       Date:  2009 Jan-Feb       Impact factor: 1.845

Review 4.  Inhaled nitric oxide in inhalation injury.

Authors:  Robert L Sheridan; Dean Hess
Journal:  J Burn Care Res       Date:  2009 Jan-Feb       Impact factor: 1.845

Review 5.  Use of nebulized heparin in the treatment of smoke inhalation injury.

Authors:  Perenlei Enkhbaatar; David N Herndon; Daniel L Traber
Journal:  J Burn Care Res       Date:  2009 Jan-Feb       Impact factor: 1.845

6.  Toxic chemicals versus lung tissue--an aspect of inhalation injury revisited. The Everett Idris Evans memorial lecture--1986.

Authors:  J W Davies
Journal:  J Burn Care Rehabil       Date:  1986 May-Jun

7.  Inhalation injury, pulmonary perturbations, and fluid resuscitation.

Authors:  Frederick W Endorf; Richard L Gamelli
Journal:  J Burn Care Res       Date:  2007 Jan-Feb       Impact factor: 1.845

8.  Inhalation injury assessed by score does not contribute to the development of acute respiratory distress syndrome in burn victims.

Authors:  G Liffner; Z Bak; A Reske; F Sjöberg
Journal:  Burns       Date:  2005-01-20       Impact factor: 2.744

9.  Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion.

Authors:  J G Laffey; M Tanaka; D Engelberts; X Luo; S Yuan; A K Tanswell; M Post; T Lindsay; B P Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

10.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.